✦ LIBER ✦

O-156 Randomized, phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated, extensive-stage, small-cell lung cancer (SCLC)

✍ Scribed by Langer, C.; Hanna, N.; Einhorn, L.; Sandler, A.; Ansari, R.; Ellis, P.; Byrne, M.; Green, M.; Morrison, M.; Bunn, P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin–etoposide alternating with top

✍ Mavroudis, D; Veslemes, M; Kouroussis, Ch; Tzanakis, N; Ferdoutsis, E; Toumbis, 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Randomized, phase II study of topotecan/

✍ H. Lena; J. Breton; W. Yu; K. Steppert; K. Lightcap; G. Ross; M. Lymboura 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB

A phase II trial of cisplatin and irinot

✍ Masahiro Tabata; Katsuyuki Kiura; Niro Okimoto; Yoshihiko Segawa; Tetsu Shinkai; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 262 KB

A multicenter randomized phase III study

✍ Mavroudis, D; Papadakis, E; Veslemes, M; Agelidou, M; Tsiafaki, X; Agelidou, G; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 103 KB

O-280 Phase III study comparing irinotec

✍ Alan, Sandler; Langer, Corey J.; Bunn, Paul A.; Einhorn, Lawrence H. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Randomised Phase II study of topotecan/c

✍ Gervais, R; Quoix, E; Mattson, K; Schramel, F.M; Rivière, A; Fields, S; Wheatley 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB